Tikcro Technologies

Antigen Design Technology for New Functional Blocking Antibodies

Health Tech & Life Sciences

Non Active, May 2021 ceased to operate

Mature Ness Ziona Founded 1999

Website ↗

Total raised

—

Stage

Mature

Founded

1999

Headcount

Ness Ziona

Sector

Health Tech & Life Sciences

About

Tikcro Technologies is leveraging a novel 3D antigen design technology in order to generate new antibodies that block receptor/ligand surface domains of immune modulators and re-activate the body's immune system to fight cancer. The company has had extensive collaborative research with the Weizmann Institute of Science in Israel.

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Technologies

Materials & Substances

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology

Business model

B2B

Name	Tikcro Technologies
Slug	tikcro-technologies
Type	Israeli Startup
Founded	1999
HQ city	Ness Ziona
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object], [object Object]
Status	inactive
Current stage	Mature
Public stage	Mature
Total raised (USD)	0
Website	https://tikcro.com/
Crunchbase ID	tikcro
Israeli Companies Registrar	512868837

Tikcro Technologies

About

Sectors & technology

Tags